ARTICLE | Company News
MRIGlobal, Thermo Fisher other news
October 24, 2016 7:00 AM UTC
HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded MRIGlobal, Thermo Fisher and the university a contract to develop the ARad Biodosimetry Test. The qPCR-based blood sample assay quantifies absorbed levels of ionizing radiation following a radiation or nuclear incident by tracking gene expression for up to seven days postexposure. ...